RBC Capital Markets downgraded Endologix Inc. (NASDAQ:ELGX) from Outperform to Sector Perform in a statement released earlier today.
- Updated: September 18, 2016
RBC Capital Markets has downgraded Endologix Inc.(NASDAQ:ELGX) from Outperform to Sector Perform in a statement released on 8/03/2016.
On 7/07/2016, BMO Capital Markets released a statement about Endologix Inc.(NASDAQ:ELGX) raised the target price from $11.50 to $16.00 that indicated a possible upside of 0.17%.
Showing a price of $13.75, Endologix Inc. (NASDAQ:ELGX) traded 1.58% higher on the day. The last stock price is up 11.93% from the two hundred day moving average, compared to the Standard & Poor’s 500 Index which has decreased -0.01% over the same time. ELGX has registered a 50-day average of $12.39 and two hundred day moving average of $11.51. Trade volume was was down over the average, with 966,947 shares of ELGX changing hands under the typical 1,052,460 shares.
With a market capitalization of $0.0, Endologix Inc. has a P/E of 0 with a 52 week low of $6.51 and a 52 week high of $14.50.
A total of 11 brokerages have released a report on Endologix Inc.. Six analysts rate the company a strong buy, four analysts rate the company a buy, one analyst rate the stock a hold, 0 rate the stock to underperform, and finally 0 brokeragesrate the stock as sell with a consensus target of $15.41
About Endologix Inc. (NASDAQ:ELGX)
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and and catheter introducer sheaths.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.